Search - tctmd.com

Displaying 281 - 300 of 314

Sort: Relevancy | Date

News Conference News Cell Therapy 2014

Repeat Cell Therapy for Chronic Heart Failure Being Tested in Randomized Trials

January 26, 2014

News Conference News AHA 2013

Varying Cell Therapy Techniques Demonstrate Safety, Mixed Efficacy at AHA 2013

November 17, 2013

News Conference News ESC 2013

Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation

Caitlin E. Cox

September 04, 2013

News Daily News

Primed Mesenchymal Stem Cells May Improve Heart Function

Caitlin E. Cox

April 12, 2013

News Daily News

Las Células Madre Mesenquimales Cebadas podrían Mejorar la Función Cardíaca

Caitlin E. Cox

April 12, 2013

News Daily News

Remote Postconditioning Reduces AKI in NSTEMI Patients

March 15, 2013

News Daily News

La Terapia Celular resulta Prometedora contra la Isquemia Crítica de las Extremidades

December 03, 2012

News Daily News

Cell Therapy Shows Promise for Critical Limb Ischemia

December 03, 2012

News Daily News

Refined Approach to Pulmonary Angioplasty Leads to Better Outcomes

Caitlin E. Cox

December 02, 2012

News Conference News AHA 2012

Cell Therapy Trials Show Mixed Results at AHA 2012

November 05, 2012

News Conference News TCT 2012

Future Looks Bright for Stem Cell-Based Myocardial Therapy

October 26, 2012

News Conference News TCT 2012

TCT Career Achievement Award Goes to CV Pathologist Renu Virmani, MD

October 26, 2012

News Conference News TCT 2012

Centrifugal Pump Feasible Treatment for Refractory RV Failure

October 25, 2012

News Industry News

NeoChord’s mitral valve repair device to be featured at 26th Annual Meeting of the European Association for Cardio-Thoracic Surgery (EACTS)

October 25, 2012

News Industry News

CircuLite® Presents Positive Hemodynamic, Exercise Tolerance and Quality of Life Data for SYNERGY® Circulatory Support System at Heart Failure Society of America Scientific Meeting

September 10, 2012

News Conference News ESC 2012

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Caitlin E. Cox

August 29, 2012

News Conference News ESC 2012

Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension

August 29, 2012

News Industry News

JARVIK HEART Announces Full FDA Approval of the Jarvik 2000 Destination Therapy Trial

August 14, 2012

News Industry News

Preliminary results demonstrate that the novel delivery of dexamethasone via Mercator’s platform Micro-Infusion Catheter inhibits restenosis for at least 9 months in 10 patients treated for peripheral

July 16, 2012

News Daily News

Un Estudio Piloto Sugiere que la Terapia Celular es Segura contra el ACV Isquémico

Caitlin E. Cox

July 09, 2012

Advertisement

Repeat Cell Therapy for Chronic Heart Failure Being Tested in Randomized Trials

Varying Cell Therapy Techniques Demonstrate Safety, Mixed Efficacy at AHA 2013

Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation

Primed Mesenchymal Stem Cells May Improve Heart Function

Las Células Madre Mesenquimales Cebadas podrían Mejorar la Función Cardíaca

Remote Postconditioning Reduces AKI in NSTEMI Patients

La Terapia Celular resulta Prometedora contra la Isquemia Crítica de las Extremidades

Cell Therapy Shows Promise for Critical Limb Ischemia

Refined Approach to Pulmonary Angioplasty Leads to Better Outcomes

Cell Therapy Trials Show Mixed Results at AHA 2012

Future Looks Bright for Stem Cell-Based Myocardial Therapy

TCT Career Achievement Award Goes to CV Pathologist Renu Virmani, MD

Centrifugal Pump Feasible Treatment for Refractory RV Failure

NeoChord’s mitral valve repair device to be featured at 26th Annual Meeting of the European Association for Cardio-Thoracic Surgery (EACTS)

CircuLite® Presents Positive Hemodynamic, Exercise Tolerance and Quality of Life Data for SYNERGY® Circulatory Support System at Heart Failure Society of America Scientific Meeting

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension

JARVIK HEART Announces Full FDA Approval of the Jarvik 2000 Destination Therapy Trial

Preliminary results demonstrate that the novel delivery of dexamethasone via Mercator’s platform Micro-Infusion Catheter inhibits restenosis for at least 9 months in 10 patients treated for peripheral

Un Estudio Piloto Sugiere que la Terapia Celular es Segura contra el ACV Isquémico

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content